Market
What will be the outcome of the $190M Pediatric Cancer Research Bill H.R.3391 in the Senate by June 30, 2025?
2
Resolution / Starting Odds
Passed • 25%
Rejected • 25%
Amended • 25%
No Action • 25%
Official records from the U.S. Senate or announcements from credible news sources
Story
$190 Million Pediatric Cancer Research Bill H.R.3391 Stalls in Senate Under Schumer
Dec 20, 2024, 05:18 PM
A $190 million funding bill for pediatric cancer research, known as H.R.3391 - Gabriella Miller Kids First Research Act 2.0, was passed by the Republican-led House on March 5, 2024, with a vote of 384-4. However, the bill has been stalled in the Democrat-controlled Senate, led by Majority Leader Chuck Schumer, since it was received on March 6, 2024. Democrats have criticized Republicans for not including this funding in a recent continuing resolution (CR), with House Democratic Leader Hakeem Jeffries accusing Republicans of prioritizing tax cuts for billionaire donors over funding for child cancer research. Republicans have countered that the bill could be passed by the Senate at any time but has been used as a bargaining chip by Democrats.
View original story
Similar markets
Moderate advancements • 25%
No noticeable advancements • 25%
Minimal advancements • 25%
Significant advancements • 25%
Other allocation strategy • 25%
Majority to existing programs • 25%
Majority to new initiatives • 25%
Even split between existing and new • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Passed but not signed into law • 25%
No vote held • 25%
Not passed • 25%
Passed and signed into law • 25%
Neutral • 25%
No official stance • 25%
Supportive • 25%
Opposed • 25%
Not Considered • 25%
Amended and Passed • 25%
Fail • 25%
Pass • 25%
Yes • 50%
No • 50%
Somewhat effective • 25%
Undecided/No opinion • 25%
Not effective • 25%
Very effective • 25%
Chuck Schumer praises the bill • 25%
Joe Biden praises the bill • 25%
Other significant response • 25%
Republicans criticize the bill • 25%